Steven Girgenti - Apr 3, 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
Director
Signature
/s/ Maria Zannes, as attorney-in-fact for Steven Girgenti
Stock symbol
BIAF
Transactions as of
Apr 3, 2024
Transactions value $
$323
Form type
4
Date filed
4/24/2024, 04:00 PM
Previous filing
Mar 29, 2024
Next filing
Jun 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIAF Common Stock Options Exercise $75.2K +64.8K +6.54% $1.16 1.06M Apr 3, 2024 Direct
transaction BIAF Common Stock Tax liability -$74.9K -33.4K -3.16% $2.24 1.02M Apr 3, 2024 Direct F1
holding BIAF Common Stock 8.96K Apr 3, 2024 By Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIAF Stock Option (right to buy) Options Exercise $0 -64.8K -100% $0.00* 0 Apr 3, 2024 Common Stock 64.8K $1.16 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to cover the exercise price of the options exercised.
F2 These shares are owned directly by the Cranye Girgenti Testamentary Trust (the "Trust"). The reporting person is a co-trustee of the Trust. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3 This option vested in 7 equal monthly installments beginning on April 28, 2014.